These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2838357)

  • 1. Effect of tolbutamide and glyburide on cAMP-dependent protein kinase activity in rat liver cytosol.
    Okuno S; Inaba M; Nishizawa Y; Inoue A; Morii H
    Diabetes; 1988 Jul; 37(7):857-61. PubMed ID: 2838357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylureas inhibit metabolic flux through rat liver pyruvate carboxylase reaction.
    White CW; Rashed HM; Patel TB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):971-4. PubMed ID: 3138409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The positive inotropic action of sulfonylureas. A mechanism independent of cyclic adenosine 3',5'-monophosphate.
    Linden J; Brooker G
    Diabetes; 1978 Jun; 27(6):694-8. PubMed ID: 207609
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sulfonylureas on hepatic fatty acid oxidation.
    Patel TB
    Am J Physiol; 1986 Aug; 251(2 Pt 1):E241-6. PubMed ID: 3090894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolbutamide inhibits cAMP-dependent phosphorylation of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Aoki M; Kaku K; Inoue H; Matsutani A; Kaneko T
    Diabetes; 1992 Mar; 41(3):334-8. PubMed ID: 1312965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tolbutamide and glyburide on pyruvate kinase flux in isolated rat hepatocytes.
    Judd RL; Kunjathoor VV; Pillai UA; Ferguson PW; Medon PJ
    Life Sci; 1992; 50(23):PL203-8. PubMed ID: 1317934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes.
    Cooper DR; Vila MC; Watson JE; Nair G; Pollet RJ; Standaert M; Farese RV
    Diabetes; 1990 Nov; 39(11):1399-407. PubMed ID: 2121569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of protein kinases from bovine parotid glands. The effect of tolbutamide and its derivative on these partially purified enzymes.
    Kanamori T; Hayakawa T; Nagatsu T
    Biochim Biophys Acta; 1976 Mar; 429(1):147-62. PubMed ID: 4116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antilipolytic action of tolbutamide in isolated fat cells of the rat.
    Allen DO; Largis EE; Ashmore J
    Diabetes; 1974 Jan; 23(1):51-4. PubMed ID: 4358605
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of soluble ovarian adenosine 3',5'-monophosphate-dependent protein kinase activity during prepubertal development of the rat.
    Hunzicker-Dunn M; Jungmann RA; Evely L; Hadawi GL; Maizels ET; West DE
    Endocrinology; 1984 Jul; 115(1):302-11. PubMed ID: 6329653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP-signaling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca2+ in rat pancreatic beta-cells.
    Yaekura K; Kakei M; Yada T
    Diabetes; 1996 Mar; 45(3):295-301. PubMed ID: 8593933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of biliary glutathione secretion by sulfonylureas.
    Patel TB; Rashed HM; Dyson J; Waller FM
    Mol Pharmacol; 1987 Jun; 31(6):638-42. PubMed ID: 3110590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of sulfonylureas with pancreatic beta-cells. A study with glyburide.
    Gorus FK; Schuit FC; In't Veld PA; Gepts W; Pipeleers DG
    Diabetes; 1988 Aug; 37(8):1090-5. PubMed ID: 2839387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone increases type I adenosine 3', 5'-monophosphate-dependent protein kinase and casein kinase activities in rat liver cytosol: analysis of protein kinases by polyacrylamide disc gel electrophoresis.
    Nakamura H; Rue PA; DeGroot LJ
    Endocrinology; 1983 Apr; 112(4):1427-33. PubMed ID: 6299694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of kidney plasma membrane adenosine-3',5'-monophosphate-dependent protein kinase.
    Forte LR; Chao WT; Walkenbach J; Byington KH
    Biochim Biophys Acta; 1975 Apr; 389(1):84-96. PubMed ID: 166673
    [No Abstract]   [Full Text] [Related]  

  • 16. The inhibitory effect of tolbutamide on phosphoenolpyruvate carboxykinase activity in rat hepatoma H4IIE cells.
    Emoto M; Inoue Y; Kaku K; Kaneko T
    Biochem Biophys Res Commun; 1993 Mar; 191(2):465-71. PubMed ID: 8384841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-dependent protein kinase and protein phosphorylation in developing rat lung.
    Whitsett JA; Matz S; Darovec-Beckerman C
    Pediatr Res; 1983 Dec; 17(12):959-66. PubMed ID: 6318184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity.
    Warnick PR; Davis FB; Davis PJ; Mylotte KM; Blas SD
    Diabetes; 1986 Sep; 35(9):1044-8. PubMed ID: 2943619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels.
    Ashford ML; Boden PR; Treherne JM
    Br J Pharmacol; 1990 Nov; 101(3):531-40. PubMed ID: 2127550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolbutamide and glyburide differ in effectiveness to displace alpha- and beta-adrenergic radioligands in pancreatic islet cells and membranes.
    Cherksey B; Altszuler N
    Diabetes; 1984 May; 33(5):499-503. PubMed ID: 6327436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.